Experience and Care Pathway of Patients with Lung Cancer: An Online International Survey
Both medical and external factors impact experiences and outcomes of patients living with LC, including the role of family in treatment and QoL discussions. There are intercountry differences in knowledge and disease management.
Authors
- A. Ciupek (ORCID: https://orcid.org/0000-0003-4203-3946)
- Pauline Frank (ORCID: https://orcid.org/0009-0003-5023-9087)
- Lorraine Dallas (ORCID: https://orcid.org/0000-0002-7870-3537)
- Pasquale Varriale (ORCID: https://orcid.org/0000-0002-8154-3124)
- Julie Laurent (ORCID: https://orcid.org/0000-0002-1705-7631)
Institutions
- Novartis (Switzerland) (CH)
- Roy Castle Lung Cancer Foundation (GB)
- Go2 for Lung Cancer (US)
- Qiagen (Switzerland) (CH)
Publication Details
- Journal
- Oncology and Therapy
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1007/s40487-024-00314-2
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00